Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Matinas Biopharma Holdings, Inc. (MTNB) had Income from Continuous Operations of $-1.91M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-1.91M |
|
-- |
|
-- |
|
$1.60M |
|
$-1.60M |
|
$-0.31M |
|
$-1.91M |
|
$-1.84M |
|
$-1.91M |
|
|
Income from Continuous Operations |
$-1.91M |
$-1.91M |
|
$-1.84M |
|
$-1.60M |
|
$-1.50M |
|
5.47M |
|
5.47M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$4.08M |
|
$0.14M |
|
$3.13M |
|
$7.21M |
|
$1.46M |
|
$0.01M |
|
$0.92M |
|
$2.38M |
|
$4.83M |
|
$4.83M |
|
$4.83M |
|
6.41M |
|
| Cash Flow Statement Financials | |
$-7.01M |
|
$0.34M |
|
$3.39M |
|
$7.53M |
|
$4.25M |
|
$-3.29M |
|
$1.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.79 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-39.59% |
|
-39.59% |
|
-26.53% |
|
-39.55% |
|
$0.75 |
|
$-1.22 |
|
$-1.28 |
|